Literature DB >> 8980974

Low intensity peripheral muscle conditioning improves exercise tolerance and breathlessness in COPD.

C J Clark1, L Cochrane, E Mackay.   

Abstract

This randomized, controlled study investigated the physiological effects of a specially designed 12 week programme of isolated conditioning of peripheral skeletal muscle groups. The programme required minimal infrastructure in order to allow continued rehabilitation at home after familiarization within hospital. Forty eight patients, aged 40-72 yrs with chronic obstructive pulmonary disease (COPD) (mean (SD) forced expiratory volume in one second (FEV1) 61 (27)% of predicted normal) were randomly allocated into training (n = 32) and control (n = 16) groups. Physiological assessments were performed before and after the 12 week study period, and included peripheral muscle endurance and strength, whole body endurance, maximal exercise capacity (maximum oxygen consumption (V'O2,max)) and lung function. The training group showed significant improvement in a variety of measures of upper and lower peripheral muscle performance, with no additional breathlessness. Whole body endurance measured by free arm treadmill walking increased by 6,372 (3,932-8,812) 3 (p < 0.001). Symptom-limited maximal V'O2 was unchanged. However, the training group showed a reduction in ventilatory equivalents for oxygen and carbon dioxide, both at peak exercise and at equivalent work rate (Wmax). In summary, low intensity isolated peripheral muscle conditioning is well-tolerated, simple and easy to perform at home. The various physiological benefits should enable patients across the range of severity of chronic obstructive pulmonary disease to improve daily functioning.

Entities:  

Mesh:

Year:  1996        PMID: 8980974     DOI: 10.1183/09031936.96.09122590

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  18 in total

Review 1.  Enhancing physical performance in chronic obstructive pulmonary disease.

Authors:  M C Steiner; M D Morgan
Journal:  Thorax       Date:  2001-01       Impact factor: 9.139

Review 2.  Pulmonary rehabilitation.

Authors: 
Journal:  Thorax       Date:  2001-11       Impact factor: 9.139

3.  The new contract: renaissance or requiem for general practice?

Authors:  Martin Marshall; Martin Roland
Journal:  Br J Gen Pract       Date:  2002-07       Impact factor: 5.386

4.  The contribution of exercise testing in the prescription and outcome evaluation of exercise training in pulmonary rehabilitation.

Authors:  Carmen Stroescu; Diana Ionita; Alina Croitoru; Claudia Toma; Bianca Paraschiv
Journal:  Maedica (Buchar)       Date:  2012-01

5.  Effect of pulmonary rehabilitation on exhaled nitric oxide in patients with chronic obstructive pulmonary disease.

Authors:  E Clini; L Bianchi; K Foglio; R Porta; M Vitacca; N Ambrosino
Journal:  Thorax       Date:  2001-07       Impact factor: 9.139

Review 6.  Effects of resistance training on respiratory function in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.

Authors:  Barbara Strasser; Uwe Siebert; Wolfgang Schobersberger
Journal:  Sleep Breath       Date:  2012-03-07       Impact factor: 2.816

Review 7.  Effects of physical activity in mild to moderate COPD: a systematic review.

Authors:  Niels Chavannes; J J H Vollenberg; C P van Schayck; E F M Wouters
Journal:  Br J Gen Pract       Date:  2002-07       Impact factor: 5.386

8.  Does pulmonary rehabilitation work in clinical practice? A review on selection and dropout in randomized controlled trials on pulmonary rehabilitation.

Authors:  Bodil Bjoernshave; Jens Korsgaard; Claus Vinther Nielsen
Journal:  Clin Epidemiol       Date:  2010-08-09       Impact factor: 4.790

Review 9.  Chronic obstructive pulmonary disease 8: non-pharmacological management of COPD.

Authors:  M D L Morgan; J R Britton
Journal:  Thorax       Date:  2003-05       Impact factor: 9.139

10.  The effects of resistance training on functional outcomes in patients with chronic obstructive pulmonary disease.

Authors:  Lynn B Panton; Jamie Golden; Craig E Broeder; Kathy D Browder; Deborah J Cestaro-Seifer; Frederic D Seifer
Journal:  Eur J Appl Physiol       Date:  2003-11-25       Impact factor: 3.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.